Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
|Articles|October 2, 2014
- Pharmaceutical Technology-10-02-2014
- Volume 38
- Issue 10
GEA Pharma Systems Valves Contain Powders
GEA Pharma Systems' Buck MC valves are designed to address powder-handling needs for solid dosage form production.
GEA Pharma Systems’ Buck MC valves are designed to address powder-handling needs for solid-dosage form production. The valves are GMP compliant and offer a dust- and contamination-free interface, removable hoppers, supplementary extraction for increased safety, and split butterfly valves to facilitate quick and effective product changeover.
Additional features include single level, simple application solutions, and multiple-level, integrated dispensary management systems. Bulk ingredient dispensing includes automated excipient dosing or interfacing with bulk ingredients for high containment. A contained charge vessel allows for the safe transportation of APIs within the plant.
GEA Pharma Systems AG
Articles in this issue
about 12 years ago
Ross Agitated Vessel Includes Silicone Heating Blanketsabout 12 years ago
Biopharma Manufacturers Respond to Ebola Crisisabout 12 years ago
Determining Facility Mold Infectionabout 12 years ago
Romaco Kilian's Tablet Press Introduces Continuous Weight Controlabout 12 years ago
Packaging Addresses Cold-Chain Requirementsabout 12 years ago
Fluorination Remains Key Challenge in API Synthesisabout 12 years ago
Fette Tablet Press Designed for High Productionabout 12 years ago
Marrying Big Data with Personalized Medicineabout 12 years ago
Bolstering Graduate Education and Research ProgramsRelated to this article
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Terry Katz, CEO and cofounder of ForgeStop Technology Corporation, explains the company’s CPHI Award-winning connected product technology and how it helps to combat drug counterfeiting.
Bettina Brierley, chief commercial officer at Celtic Renewables, discusses commercialization of biosolvents for pharmaceutical manufacturing.
Coverage from AAPS PharmSci 360 and CPHI Milan featured discussion about impurities, devices, and supply resilience. This week also included topics such as AI accountability, oral peptides, and new licensing deals.
CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing
Onshoring pharmaceutical manufacturing can be made more practical by collaborating with CDMOs that have gray space, supported by strong relationships with used equipment dealers and OEMs.
USP data show fewer US drug shortages but longer ones, averaging 5+ years. Drug shortages are an incentive problem, not a manufacturing mystery.
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
Our Biggest Takeaways From AAPS PharmSci 360
3
$1.15B AI-Guided Macrocycle Discovery Lands at argenx
4
PharmTech AI Pulse Check: Who's Accountable When a Vendor's AI Model Changes?
5